73 related articles for article (PubMed ID: 19887196)
41. Thrombospondins Differentially Regulate Proteins Involved in Arterial Remodeling.
Kassem MM; Helkin A; Maier KG; Gahtan V
Physiol Res; 2019 Dec; 68(6):893-900. PubMed ID: 31647293
[TBL] [Abstract][Full Text] [Related]
42. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.
Lawler PR; Lawler J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006627. PubMed ID: 22553494
[TBL] [Abstract][Full Text] [Related]
43. Emodin Inhibits the Indoxyl Sulfate-Induced trans-Differentiation of Vascular Smooth Muscle Cells through Upregulating Thrombospondin-1.
Zhang W; Chen J; Tan X; Zhang P; Xu X; Ding X; Zhao S; Jin S
J Vasc Res; 2023; 60(4):193-203. PubMed ID: 37669629
[TBL] [Abstract][Full Text] [Related]
44. Development of an enzyme-linked immunosorbent assay for thrombospondin-1 and comparison of human plasma and serum concentrations.
Barclay JL; Keshvari S; Whitehead JP; Inder WJ
Ann Clin Biochem; 2016 Sep; 53(Pt 5):606-10. PubMed ID: 26748102
[TBL] [Abstract][Full Text] [Related]
45. Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways.
Spiekerkoetter E; Lawrie A; Merklinger S; Ambartsumian N; Lukanidin E; Schmidt AM; Rabinovitch M
Chest; 2005 Dec; 128(6 Suppl):577S. PubMed ID: 16373840
[No Abstract] [Full Text] [Related]
46. Cross-linked and hydrophobized hyaluronic acid-based controlled drug release systems.
Csapó E; Szokolai H; Juhász Á; Varga N; Janovák L; Dékány I
Carbohydr Polym; 2018 Sep; 195():99-106. PubMed ID: 29805030
[TBL] [Abstract][Full Text] [Related]
47. Cardiovascular Effects Mediated by HMMR and CD44.
Jaskuła K; Sacharczuk M; Gaciong Z; Skiba DS
Mediators Inflamm; 2021; 2021():4977209. PubMed ID: 34335086
[TBL] [Abstract][Full Text] [Related]
48. Thrombospondin-1 differentially regulates microRNAs in vascular smooth muscle cells.
Maier KG; Ruhle B; Stein JJ; Gentile KL; Middleton FA; Gahtan V
Mol Cell Biochem; 2016 Jan; 412(1-2):111-7. PubMed ID: 26728995
[TBL] [Abstract][Full Text] [Related]
49. Thrombospondin-1-induced smooth muscle cell chemotaxis and proliferation are dependent on transforming growth factor-β2 and hyaluronic acid synthase.
Stein JJ; Iwuchukwu C; Maier KG; Gahtan V
Mol Cell Biochem; 2013 Dec; 384(1-2):181-6. PubMed ID: 24104451
[TBL] [Abstract][Full Text] [Related]
50. Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors.
Trujillo G; Zhang J; Habiel DM; Ge L; Ramadass M; Ghebrehiwet B; Kew RR
Mol Immunol; 2011 Dec; 49(3):495-503. PubMed ID: 22014686
[TBL] [Abstract][Full Text] [Related]
51. Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid.
Anitua E; Sanchez M; De la Fuente M; Zalduendo MM; Orive G
Knee Surg Sports Traumatol Arthrosc; 2012 Sep; 20(9):1657-65. PubMed ID: 21987365
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.
Roubelakis MG; Bitsika V; Zagoura D; Trohatou O; Pappa KI; Makridakis M; Antsaklis A; Vlahou A; Anagnou NP
J Cell Mol Med; 2011 Sep; 15(9):1896-913. PubMed ID: 21166769
[TBL] [Abstract][Full Text] [Related]
53. Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
Ochoa CD; Yu L; Al-Ansari E; Hales CA; Quinn DA
J Cardiothorac Surg; 2010 May; 5():32. PubMed ID: 20441584
[TBL] [Abstract][Full Text] [Related]
54. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44.
Maier KG; Sadowitz B; Cullen S; Han X; Gahtan V
Am J Surg; 2009 Nov; 198(5):664-9. PubMed ID: 19887196
[TBL] [Abstract][Full Text] [Related]
55. The role of G proteins in thromospondin-1-induced vascular smooth muscle cell migration.
Fuse S; Esemuede N; Yamaguchi M; Maier KG; Nesselroth SM; Sumpio BE; Gahtan V
Surgery; 2008 Jul; 144(1):86-92. PubMed ID: 18571589
[TBL] [Abstract][Full Text] [Related]
56. The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis.
Nesselroth SM; Willis AI; Fuse S; Olson ET; Lawler J; Sumpio BE; Gahtan V
J Vasc Surg; 2001 Mar; 33(3):595-600. PubMed ID: 11241132
[TBL] [Abstract][Full Text] [Related]
57. Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: the role of the type 3 repeat and carboxyl terminal domains.
Lee T; Nesselroth SM; Olson ET; Esemuede N; Lawler J; Sumpio BE; Gahtan V
J Cell Biochem; 2003 Jun; 89(3):500-6. PubMed ID: 12761883
[TBL] [Abstract][Full Text] [Related]
58. [Role of thrombospondin-1 in hypoxia-induced migration of human vascular smooth muscle cells].
Takahashi M; Oka M; Ikeda T; Akiba S; Sato T
Yakugaku Zasshi; 2008 Mar; 128(3):377-83. PubMed ID: 18311056
[TBL] [Abstract][Full Text] [Related]
59. The role of thrombospondin-1 in cardiovascular health and pathology.
Krishna SM; Golledge J
Int J Cardiol; 2013 Sep; 168(2):692-706. PubMed ID: 23664438
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
